Pastilles overtake flower as most prescribed dosage form for women by Steve Jones September 2, 2026September 2, 2026 Pastilles have overtaken flower to become the most prescribed dosage form for women through the Special […]
SAS-B deep dive: June hits new record for TGA approvals as pastilles surge and oil declines by Steve Jones July 8, 2026July 8, 2026
May SAS-B approvals hit 2026 high as Victoria extends prescribing lead by Adam Sheldon June 3, 2026June 4, 2026
April SAS-B figures: pastilles hit nearly one-third of approvals by Adam Sheldon May 7, 2026May 7, 2026
Bioxyne lifts FY26 guidance after margin growth in strong first half by Steve Jones February 26, 2026February 26, 2026
TGA offers first clues to where industry can expect to face regulatory reform by Steve Jones February 23, 2026February 25, 2026
Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026
